Depression is a serious brain condition which affects around six million people in this country. 8.9 % of men and 16.5 % of women suffer from it and, unlike other illnesses, its incidence has been increasing over the last decades.
The depressed are characterised by mood, behavioural and somatic disorders which become chronic in 25% of the cases, if not detected and properly treated. The condition may emerge at any age, causing great incapacity for users suffering from this. Major Depression will in fact be the second cause of incapacity in 2020, according to the World Health Organisation.
This is a large-scale health problem with a great economic, social and also personal cost since Major Depression is involved in 70% of consummated suicides, for example.
The projects and results obtained by our researchers focus on the evaluation of impact and risk factors of depression, implementing and evaluating programmes for prevention and early detection and of suicidal depression and conduct. The programme has some important national and international projects concentrating on the search for the causes of this illness essentially by genetics and its interaction with the environment as well as in the search for and appraisal of new treatments, especially in patients who do not improve with the treatments that we currently have available.
|Main Researcher||Consortium Institution||Regions||Details|
|Jorge A Cervilla Ballesteros||Universidad de Granada. Facultad de Medicina||Andalucía||View group|
|José Manuel Menchon Magriña||Hospital Universitario de Bellvitge||Cataluña||View group|
|Ángel Armando Pazos Carro||Universidad de Cantabria. Facultad de Medicina||Cantabria||View group|
|Víctor Pérez Sola||Hospital de la Santa Creu i Sant Pau||Cataluña||View group|
|José Luis Ayuso Mateos||Hospital Universitario La Princesa||Madrid||View group|
|Francesc Artigas Pérez||Instituto de Investigaciones Biomédicas de Barcelona||Cataluña||View group|